Resmed (RMD) Return on Capital Employed (2010 - 2026)

Resmed's Return on Capital Employed history runs 17 years deep, the most recent figure standing at 25.95% for Q1 2026.

• Quarterly Return on Capital Employed rose 82.0% year-over-year to 25.95% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 25.95% (up 82.0% YoY) and the FY2025 annual result came in at 25.91%, up 355.0% from the prior year.
• Return on Capital Employed was 25.95% for Q1 2026 at Resmed, up from 25.41% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 25.95% in Q1 2026 and bottomed at 18.74% in Q1 2023.
• A 5-year average of 22.45% and a median of 23.09% in 2024 frame the typical range for Return on Capital Employed.
• Annual changes were most pronounced in 2023 — Return on Capital Employed plunged 501 bps — and 2024, when it soared 583 bps.
• Resmed's Return on Capital Employed stood at 20.13% in 2022, then declined by 7 bps to 18.82% in 2023, then soared by 31 bps to 24.65% in 2024, then rose by 3 bps to 25.41% in 2025, then increased by 2 bps to 25.95% in 2026.
• Business Quant data shows RMD's Return on Capital Employed at 25.95% in Q1 2026, 25.41% in Q4 2025, and 24.97% in Q3 2025.